Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Cytokinetics Aktie: Wissenschaftlicher Prüfstand


Cytokinetics bereitet sich auf einen wichtigen Auftritt beim Jahreskongress des American College of Cardiology…

Der Beitrag Cytokinetics Aktie: Wissenschaftlicher Prüfstand erschien zuerst auf kapitalmarktexperten.de.


Quelle kapitalmarktexperten.de

Cytokinetics Inc. Stock

€56.68
0.940%
Cytokinetics Inc. gained 0.940% compared to yesterday.
The stock is an absolute favorite of our community with 42 Buy predictions and no Sell predictions.
As a result the target price of 72 € shows a positive potential of 27.03% compared to the current price of 56.68 € for Cytokinetics Inc..

Comments